0001193125-23-064969.txt : 20230309 0001193125-23-064969.hdr.sgml : 20230309 20230308213757 ACCESSION NUMBER: 0001193125-23-064969 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 23718014 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Moxie Dwight CENTRAL INDEX KEY: 0001803375 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 7555 GATEWAY BOULEVARD CITY: NEWARK STATE: CA ZIP: 94560 144 1 primary_doc.xml 144 0001803375 XXXXXXXX LIVE 0001479290 Revance Therapeutics, Inc. 001-36297 1222 Demonbreun St Suite 2000 Nashville TN 37203 615 724-7755 Dwight Moxie Officer COMMON E*TRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005 20000 660000.00 82800000 03/08/2023 NASD Revance Common 03/07/2023 RSU Vesting Revance Therapeutics N 20000 03/07/2023 Cash Y Shares sold to cover taxes from a RSU vest 03/08/2023 /s/ Dwight Moxie